Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice

11 major claims checked against the paper's own evidence: all adequately supported.

Recomputed 13 tests: 8 consistent, 5 inconsistent (2 change significance at p<.05), 13 via agent-written checks.

5 integrity concerns flagged (0 high).

11 copyedit issues flagged: mostly typo, consistency, clarity.

As a published paper, the robustness is compromised by the statistical inconsistencies (5 of 13 tests inconsistent, including 2 decision errors) and a mathematical plausibility issue (31% of 15 mice is non-integer). An informed reader should weigh whether these errors affect the paper's conclusions. The authors should consider issuing a correction or providing a re-analysis with corrected p-values and clarification of the rounding error. The missing data availability statement limits reproducibility.

1. 1.
   CRITICALstatistics

   Re-analyze the 5 inconsistent tests (including the 2 decision errors) identified by the statistics verification component, report corrected p-values, and re-evaluate whether conclusions change.

   5 of 13 recomputed tests were inconsistent with reported values, and 2 p-values reported as significant were non-significant on recomputation, indicating a potential data analysis error that could affect the paper's conclusions.
2. 2.
   CRITICALstatistics

   Clarify the rounding error in the strategy preference result: 31% of 15 mice is 4.65, not an integer. Provide exact counts or state that the percentage is an approximation.

   This inconsistency suggests a potential data reporting error or miscalculation that undermines the credibility of the reported result.
3. 3.
   HIGHdata code

   Add a data availability statement specifying how raw behavioral and biochemical data can be accessed (e.g., on request from the authors or via a repository).

   The current paper provides no way for readers to access the underlying data, which is a major barrier to reproducibility and verification.
4. 4.
   HIGHrigor

   Provide full identifiers (vendor, catalog number, RRID) for all antibodies and key reagents, including the source of R-flurbiprofen (manufacturer, catalog number, purity).

   Without these identifiers, other researchers cannot reproduce the experiments or verify the reagents used.
5. 5.
   HIGHrigor

   Describe the randomization method used to assign mice to treatment groups, or state clearly why randomization was not feasible.

   The current assignment based on age introduces potential confounding and is a significant methodological limitation.
6. 6.
   HIGHrigor

   Report whether investigators were blinded to treatment group during behavioral testing and data analysis, or state clearly why blinding was not performed.

   Blinding is a standard safeguard against bias; its absence is a major concern for the validity of behavioral results.
7. 7.
   HIGHstatistics

   Report exact p-values (e.g., p = 0.023) for all statistical tests instead of threshold values, and include effect sizes (e.g., Cohen's d) and 95% confidence intervals for primary outcomes.

   Threshold p-values are insufficient for precise interpretation, and effect sizes are essential for understanding the magnitude of effects.
8. 8.
   HIGHstatistics

   Identify the statistical software used (e.g., SPSS, GraphPad Prism) with version number in the Methods section.

   The software used can affect the reproducibility of analyses, and its absence is a reporting gap.
9. 9.
   MEDIUMreporting

   Add a formal conflicts of interest statement, even if stating that the authors declare no competing interests.

   Transparency about potential conflicts is a standard requirement for most journals.
10. 10.
    MEDIUMreporting

    Reference the ARRIVE guidelines for reporting animal research, and provide a completed checklist as supplementary material.

    Adherence to reporting guidelines is recommended by many journals and improves the completeness and transparency of the report.
11. 11.
    MEDIUMcopyedit

    Correct the typo in Table 2 header: 'Tg2575' should be 'Tg2576'.

    This is a clear typographical error that could cause confusion about the mouse strain used.
12. 12.
    MEDIUMcopyedit

    Standardize the drug name to 'R-flurbiprofen' throughout the manuscript (remove extra spaces and hyphens).

    Inconsistent formatting of the drug name is distracting and may appear unprofessional.
13. 13.
    MEDIUMrigor

    Provide a scientific justification for using only female mice, or discuss the implications of this limitation.

    Single-sex studies without justification may limit the generalizability of the findings.
14. 14.
    LOWreporting

    Consider showing individual data points in all figures (e.g., dot plots) alongside bar graphs to reveal distribution and variability.

    Bar graphs with error bars can obscure the underlying data distribution; individual points improve transparency.